Physician profile
Rajeev Sehgal
NPI 1184723413
$4,162.58
in general payments reported to CMS, 2019-2025
22 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $2,377 · 2021: $293 · 2022: $282 · 2023: $128 · 2024: $299 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $1,580.39 | 2019-2021 | |
| Biopro, INC. | $701.05 | 2019-2023 | |
| Smith+Nephew, INC. | $618.79 | 2019-2025 | Stravix Pl, Grafix Pl, Grafix |
| Zimmer Biomet Holdings, INC. | $142.69 | 2020-2025 | A.L.P.S., Stratum Foot Plating System |
| Paragon 28, INC. | $139.93 | 2019-2024 | Grappler, Additive Orthopedics |
| Organogenesis INC. | $133.01 | 2021 | |
| Stryker Corporation | $131.54 | 2022-2024 | Dart-Fire, Stryker, Variax |
| Integra Lifesciences Corporation | $120.90 | 2019-2021 | |
| Kci USA, INC. | $117.28 | 2019 | |
| Linvatec Corporation | $113.57 | 2025 | Neospan, Biobrace 23mm |
| Depuy Synthes Sales INC. | $92.48 | 2025 | N/A, Quickanchor Orthocord, Healix Knotless Peek |
| Kerecis Limited | $68.72 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $28.43 | 2022 | |
| Nevro Corp. | $28.28 | 2022 | |
| Bioventus LLC | $26.83 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $22.29 | 2019 | |
| Mimedx Group, INC. | $20.99 | 2025 | |
| Orthofix Medical, INC. | $17.07 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.61 | 2025 | Nuzyra |
| Pinnacle, INC | $14.90 | 2020 | |
| Aroa Biosurgery Incorporated | $14.40 | 2023 | |
| Reprise Biomedical, INC. | $12.43 | 2025 | Miro 3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Sehgal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.